| Metric | Q3-26 | Q3-25 |
|---|---|---|
| Revenue | 1.50 | 2.32 |
| Gross Profit | 0.31 | 1.13 |
| Pretax Income | -2.85 | -0.04 |
| Net Income | -2.85 | -0.29 |
- Net Income YoY
- -883.2%
Key highlights
- Quarterly revenue fell to $1.50 million, a 35.3% decrease compared to $2.32 million in Q3-2025
- Net loss widened to $2.85 million for the quarter, representing an 883.2% year-over-year decline
- Gross profit dropped to $0.31 million from $1.13 million in the prior-year period
- Nine-month revenue reached $4.94 million, showing a slight increase from $4.57 million in 2025
- Year-to-date net loss improved to $4.60 million from $6.86 million, aided by income from discontinued operations
How the Period Went
VSee Health experienced a contraction in its top-line performance during the third quarter of 2026. Revenue fell to $1.50 million, down from $2.32 million in the same period last year. This decline in sales significantly impacted the bottom line, with the company reporting a net loss of $2.85 million compared to a more modest loss of $0.29 million in Q3-2025. The year-over-year net income movement represents a decrease of 883.2%. Pretax income also moved sharply lower, shifting from a loss of $0.04 million in the prior year to a $2.85 million loss in the current reporting period, reflecting higher operational hurdles.
Margins and Profitability
- Gross profit reached $0.31 million in Q3-2026, a sharp decline from the $1.13 million reported in Q3-2025
- The company reported a nine-month net loss of $4.60 million, which is an improvement over the $6.86 million loss in the same period of 2025
- Profitability metrics for the year-to-date period were positively influenced by income attributed to discontinued operations
- Operating expenses continue to outpace gross income, leading to the widened quarterly pretax loss of $2.85 million
- The total nine-month revenue of $4.94 million suggests a slowdown in the third quarter specifically, as it represents a lower run-rate than earlier in the year
Business Overview
VSee Health, Inc. is a player in the health information services industry, focusing on providing telehealth solutions and communication platforms for the healthcare sector. The company's technology facilitates remote patient monitoring and virtual consultations, aiming to streamline clinical workflows for providers. Its core end markets include health systems and clinics looking for integrated digital health tools. While the company has historically focused on software-as-a-service models, the recent decline in quarterly revenue highlights a period of transition as the firm manages its portfolio, including the impact of discontinued operations on its broader financial structure.
Financial Context
The quarterly results coincide with significant downward pressure on the company's market valuation. VSee Health's stock price has fallen 86.93% over the last month and 25.15% in a single day, bringing its market capitalization to approximately $0.22 million. With a Relative Strength Index (RSI) of 20.3, the stock is currently trading in oversold territory according to technical indicators. Despite the current quarterly headwinds, the company maintains an annual revenue base of $14.62 million. However, the contrast between the high annual revenue and the low market cap reflects investor caution regarding the widening quarterly losses and sector-wide volatility.
| Share price | $0.25 |
|---|---|
| Market cap | $216,579 |
| Revenue (annual) | $15M |
| 1-month price change | -86.93% |
| Sector | HealthcareHealth Information Services |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
SEC filing by VSee Health, Inc. announcing its financial results for the fiscal quarter ended September 30, 2026.
Track VSEE HEALTH, INC. live
Get the next VSEE HEALTH, INC. SEC filing seconds after it lands.



